Moleculin Biotech Receives Notice of Allowance for Japanese Patent Covering Liposomal Annamycin
Reuters
Feb 17
<a href="https://laohu8.com/S/MBRX">Moleculin Biotech</a> Receives Notice of Allowance for Japanese Patent Covering Liposomal Annamycin
Moleculin Biotech Inc. announced that the Japan Patent Office has issued a notice of allowance for its patent application titled "METHOD OF RECONSTITUTING LIPOSOMAL ANNAMYCIN." A patent from the application is expected to be issued in the coming months.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9655357-en) on February 17, 2026, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.